Non-apoptotic functions of cell death effectors in inflammation and innate immunity

Microbes and Infection

Volumn 14, Issue 14, 2012, Pages 1241-1253

  Morizot, Alexandre ^a   Saleh, Maya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Innate immunity; Mitochondria; Pattern recognition receptors

Indexed keywords

CASPASE; INHIBITOR OF APOPTOSIS PROTEIN;

APOPTOSIS; CELL DEATH; CELL FUNCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MITOCHONDRION; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CELL DEATH; HUMANS; IMMUNITY, INNATE; INFLAMMATION;

EID: 84870251039     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.06.005     Document Type: Short Survey

References (152)

1. Labbé K., Saleh M. Pyroptosis: a caspase-1-dependent programmed cell death and a barrier to infection. The Inflammasomes 2011, 17-36. Springer, Basel. I. Couillin, V. Petrilli, F. Martinon (Eds.).
2. Zipfel C. Early molecular events in PAMP-triggered immunity. Curr. Opin. Plant Biol. 2009, 12:414-420.
3. Lukasik E., Takken F.L. STANDing strong, resistance proteins instigators of plant defence. Curr. Opin. Plant Biol. 2009, 12:427-436.
4. Eitas T.K., Dangl J.L. NB-LRR proteins: pairs, pieces, perception, partners, and pathways. Curr. Opin. Plant Biol. 2010, 13:472-477.
5. Mur L.A., Kenton P., Lloyd A.J., Ougham H., Prats E. The hypersensitive response; the centenary is upon us but how much do we know?. J. Exp. Bot. 2008, 59:501-520.
6. Lemaitre B., Kromer-Metzger E., Michaut L., Nicolas E., Meister M., Georgel P., Reichhart J.M., Hoffmann J.A. A recessive mutation, immune deficiency (imd), defines two distinct control pathways in the Drosophila host defense. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9465-9469.
7. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
8. Choe K.M., Werner T., Stoven S., Hultmark D., Anderson K.V. Requirement for a peptidoglycan recognition protein (PGRP) in relish activation and antibacterial immune responses in Drosophila. Science 2002, 296:359-362.
9. Gobert V., Gottar M., Matskevich A.A., Rutschmann S., Royet J., Belvin M., Hoffmann J.A., Ferrandon D. Dual activation of the Drosophila Toll pathway by two pattern recognition receptors. Science 2003, 302:2126-2130.
10. Gottar M., Gobert V., Michel T., Belvin M., Duyk G., Hoffmann J.A., Ferrandon D., Royet J. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 2002, 416:640-644.
11. Kang D., Liu G., Lundstrom A., Gelius E., Steiner H. A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10078-10082.
12. Liu C., Xu Z., Gupta D., Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J. Biol. Chem. 2001, 276:34686-34694.
13. Michel T., Reichhart J.M., Hoffmann J.A., Royet J. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature 2001, 414:756-759.
14. Ramet M., Manfruelli P., Pearson A., Mathey-Prevot B., Ezekowitz R.A. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 2002, 416:644-648.
15. Stenbak C.R., Ryu J.H., Leulier F., Pili-Floury S., Parquet C., Herve M., Chaput C., Boneca I.G., Lee W.J., Lemaitre B., Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by the Drosophila immune deficiency pathway. J. Immunol. 2004, 173:7339-7348.
16. Takehana A., Katsuyama T., Yano T., Oshima Y., Takada H., Aigaki T., Kurata S. Overexpression of a pattern-recognition receptor, peptidoglycan-recognition protein-LE, activates imd/relish-mediated antibacterial defense and the prophenoloxidase cascade in Drosophila larvae. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13705-13710.
17. Takehana A., Yano T., Mita S., Kotani A., Oshima Y., Kurata S. Peptidoglycan recognition protein (PGRP)-LE and PGRP-LC act synergistically in Drosophila immunity. EMBO J. 2004, 23:4690-4700.
18. Werner T., Liu G., Kang D., Ekengren S., Steiner H., Hultmark D. A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13772-13777.
19. Bischoff V., Vignal C., Boneca I.G., Michel T., Hoffmann J.A., Royet J. Function of the Drosophila pattern-recognition receptor PGRP-SD in the detection of Gram-positive bacteria. Nat. Immunol. 2004, 5:1175-1180.
20. Leone P., Bischoff V., Kellenberger C., Hetru C., Royet J., Roussel A. Crystal structure of Drosophila PGRP-SD suggests binding to DAP-type but not lysine-type peptidoglycan. Mol. Immunol. 2008, 45:2521-2530.
21. Wang L., Gilbert R.J., Atilano M.L., Filipe S.R., Gay N.J., Ligoxygakis P. Peptidoglycan recognition protein-SD provides versatility of receptor formation in Drosophila immunity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11881-11886.
22. Buchon N., Poidevin M., Kwon H.M., Guillou A., Sottas V., Lee B.L., Lemaitre B. A single modular serine protease integrates signals from pattern-recognition receptors upstream of the Drosophila Toll pathway. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12442-12447.
23. Jang I.H., Chosa N., Kim S.H., Nam H.J., Lemaitre B., Ochiai M., Kambris Z., Brun S., Hashimoto C., Ashida M., Brey P.T., Lee W.J. A spatzle-processing enzyme required for Toll signalling activation in Drosophila innate immunity. Dev. Cell 2006, 10:45-55.
24. Park J.W., Kim C.H., Kim J.H., Je B.R., Roh K.B., Kim S.J., Lee H.H., Ryu J.H., Lim J.H., Oh B.H., Lee W.J., Ha N.C., Lee B.L. Clustering of peptidoglycan recognition protein-SA is required for sensing lysine-type peptidoglycan in insects. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6602-6607.
25. Levashina E.A., Langley E., Green C., Gubb D., Ashburner M., Hoffmann J.A., Reichhart J.M. Constitutive activation of Toll-mediated antifungal defense in serpin-deficient Drosophila. Science 1999, 285:1917-1919.
26. Choe K.M., Lee H., Anderson K.V. Drosophila peptidoglycan recognition protein LC (PGRP-LC) acts as a signal-transducing innate immune receptor. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1122-1126.
27. Mellroth P., Karlsson J., Hakansson J., Schultz N., Goldman W.E., Steiner H. Ligand-induced dimerization of Drosophila peptidoglycan recognition proteins in vitro. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6455-6460.
28. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
29. Latz E., Visintin A., Lien E., Fitzgerald K.A., Espevik T., Golenbock D.T. The LPS receptor generates inflammatory signals from the cell surface. J. Endotoxin Res. 2003, 9:375-380.
30. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 2008, 9:361-368.
31. Tanimura N., Saitoh S., Matsumoto F., Akashi-Takamura S., Miyake K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signalling. Biochem. Biophys. Res. Commun. 2008, 368:94-99.
32. Moore K.J., Andersson L.P., Ingalls R.R., Monks B.G., Li R., Arnaout M.A., Golenbock D.T., Freeman M.W. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 2000, 165:4272-4280.
33. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 2001, 276:21129-21135.
34. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
35. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999, 285:736-739.
36. Aliprantis A.O., Yang R.B., Weiss D.S., Godowski P., Zychlinsky A. The apoptotic signalling pathway activated by Toll-like receptor-2. EMBO J. 2000, 19:3325-3336.
37. Ruckdeschel K., Pfaffinger G., Haase R., Sing A., Weighardt H., Hacker G., Holzmann B., Heesemann J. Signalling of apoptosis through TLRs critically involves Toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J. Immunol. 2004, 173:3320-3328.
38. Kaiser W.J., Offermann M.K. Apoptosis induced by the Toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J. Immunol. 2005, 174:4942-4952.
39. Ermolaeva M.A., Michallet M.C., Papadopoulou N., Utermohlen O., Kranidioti K., Kollias G., Tschopp J., Pasparakis M. Function of TRADD in tumor necrosis factor receptor 1 signalling and in TRIF-dependent inflammatory responses. Nat. Immunol. 2008, 9:1037-1046.
40. Han K.J., Su X., Xu L.G., Bin L.H., Zhang J., Shu H.B. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J. Biol. Chem. 2004, 279:15652-15661.
41. Ting J.P., Lovering R.C., Alnemri E.S., Bertin J., Boss J.M., Davis B.K., Flavell R.A., Girardin S.E., Godzik A., Harton J.A., Hoffman H.M., Hugot J.P., Inohara N., Mackenzie A., Maltais L.J., Nunez G., Ogura Y., Otten L.A., Philpott D., Reed J.C., Reith W., Schreiber S., Steimle V., Ward P.A. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287.
42. Hasegawa M., Fujimoto Y., Lucas P.C., Nakano H., Fukase K., Nunez G., Inohara N. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 2008, 27:373-383.
43. Kofoed E.M., Vance R.E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011, 477:592-595.
44. Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J.C. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25:713-724.
45. Boyden E.D., Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 2006, 38:240-244.
46. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 2010, 10:210-215.
47. Malireddi R.K., Ippagunta S., Lamkanfi M., Kanneganti T.D. Cutting edge: proteolytic inactivation of poly(ADP-ribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes. J. Immunol. 2010, 185:3127-3130.
48. Onoguchi K., Yoneyama M., Fujita T. Retinoic acid-inducible gene-I-like receptors. J. Interferon Cytokine Res. 2011, 31:27-31.
49. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signalling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
50. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
51. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
52. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
53. Oshiumi H., Matsumoto M., Hatakeyama S., Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J. Biol. Chem. 2009, 284:807-817.
54. Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006, 7:131-137.
55. Besch R., Poeck H., Hohenauer T., Senft D., Hacker G., Berking C., Hornung V., Endres S., Ruzicka T., Rothenfusser S., Hartmann G. Proapoptotic signalling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J. Clin. Invest. 2009, 119:2399-2411.
56. Chattopadhyay S., Marques J.T., Yamashita M., Peters K.L., Smith K., Desai A., Williams B.R., Sen G.C. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 2010, 29:1762-1773.
57. Poyet J.L., Srinivasula S.M., Tnani M., Razmara M., Fernandes-Alnemri T., Alnemri E.S. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 2001, 276:28309-28313.
58. Gross O., Thomas C.J., Guarda G., Tschopp J. The inflammasome: an integrated view. Immunol. Rev. 2011, 243:136-151.
59. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
60. Franchi L., Eigenbrod T., Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009, 183:792-796.
61. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
62. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007, 14:1583-1589.
63. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., Carter A.B., Rothman P.B., Flavell R.A., Sutterwala F.S. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9035-9040.
64. Meissner F., Seger R.A., Moshous D., Fischer A., Reichenbach J., Zychlinsky A. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 2010, 116:1570-1573.
65. van de Veerdonk F.L., Smeekens S.P., Joosten L.A., Kullberg B.J., Dinarello C.A., van der Meer J.W., Netea M.G. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3030-3033.
66. van Bruggen R., Koker M.Y., Jansen M., van Houdt M., Roos D., Kuijpers T.W., van den Berg T.K. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 2010, 115:5398-5400.
67. Bauernfeind F., Bartok E., Rieger A., Franchi L., Nunez G., Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 2011, 187:613-617.
68. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
69. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., Fitzgerald K.A., Ryter S.W., Choi A.M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
70. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
71. Castanier C., Garcin D., Vazquez A., Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep. 2010, 11:133-138.
72. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., Morimoto S., Julkunen I., Namiki H., Yoneyama M., Fujita T. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog. 2010, 6:e1001012.
73. Yasukawa K., Oshiumi H., Takeda M., Ishihara N., Yanagi Y., Seya T., Kawabata S., Koshiba T. Mitofusin 2 inhibits mitochondrial antiviral signalling. Sci. Signal. 2009, 2:ra47.
74. Moore C.B., Bergstralh D.T., Duncan J.A., Lei Y., Morrison T.E., Zimmermann A.G., Accavitti-Loper M.A., Madden V.J., Sun L., Ye Z., Lich J.D., Heise M.T., Chen Z., Ting J.P. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
75. Arnoult D., Soares F., Tattoli I., Castanier C., Philpott D.J., Girardin S.E. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J. Cell Sci. 2009, 122:3161-3168.
76. Allen I.C., Moore C.B., Schneider M., Lei Y., Davis B.K., Scull M.A., Gris D., Roney K.E., Zimmermann A.G., Bowzard J.B., Ranjan P., Monroe K.M., Pickles R.J., Sambhara S., Ting J.P. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signalling pathways. Immunity 2011, 34:854-865.
77. Rebsamen M., Vazquez J., Tardivel A., Guarda G., Curran J., Tschopp J. NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell Death Differ. 2011, 18:1387.
78. Tattoli I., Carneiro L.A., Jehanno M., Magalhaes J.G., Shu Y., Philpott D.J., Arnoult D., Girardin S.E. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008, 9:293-300.
79. Xia X., Cui J., Wang H.Y., Zhu L., Matsueda S., Wang Q., Yang X., Hong J., Songyang Z., Chen Z.J., Wang R.F. NLRX1 negatively regulates TLR-induced NF-kappaB signalling by targeting TRAF6 and IKK. Immunity 2011, 34:843-853.
80. Labbe K., Saleh M. Cell death in the host response to infection. Cell Death Differ. 2008, 15:1339-1349.
81. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., Zhang J., Lee W.P., Roose-Girma M., Dixit V.M. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
82. Saleh M., Mathison J.C., Wolinski M.K., Bensinger S.J., Fitzgerald P., Droin N., Ulevitch R.J., Green D.R., Nicholson D.W. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006, 440:1064-1068.
83. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.
84. Lamkanfi M., Kanneganti T.D., Van Damme P., Vanden Berghe T., Vanoverberghe I., Vandekerckhove J., Vandenabeele P., Gevaert K., Nunez G. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell. Proteomics 2008, 7:2350-2363.
85. Shao W., Yeretssian G., Doiron K., Hussain S.N., Saleh M. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 2007, 282:36321-36329.
86. Broz P., von Moltke J., Jones J.W., Vance R.E., Monack D.M. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 2010, 8:471-483.
87. Wang S., Miura M., Jung Y.K., Zhu H., Li E., Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998, 92:501-509.
88. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
89. Martinon F., Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004, 117:561-574.
90. Mueller N.J., Wilkinson R.A., Fishman J.A. Listeria monocytogenes infection in caspase-11-deficient mice. Infect. Immun. 2002, 70:2657-2664.
91. Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 2002, 277:34287-34294.
92. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403:98-103.
93. Rao R.V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., del Rio G., Bredesen D.E., Ellerby H.M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem. 2002, 277:21836-21842.
94. Di Sano F., Ferraro E., Tufi R., Achsel T., Piacentini M., Cecconi F. Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J. Biol. Chem. 2006, 281:2693-2700.
95. Saleh M., Vaillancourt J.P., Graham R.K., Huyck M., Srinivasula S.M., Alnemri E.S., Steinberg M.H., Nolan V., Baldwin C.T., Hotchkiss R.S., Buchman T.G., Zehnbauer B.A., Hayden M.R., Farrer L.A., Roy S., Nicholson D.W. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004, 429:75-79.
96. Labbe K., Miu J., Yeretssian G., Serghides L., Tam M., Finney C.A., Erdman L.K., Goulet M.L., Kain K.C., Stevenson M.M., Saleh M. Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signalling. J. Immunol. 2010, 185:5495-5502.
97. LeBlanc P.M., Yeretssian G., Rutherford N., Doiron K., Nadiri A., Zhu L., Green D.R., Gruenheid S., Saleh M. Caspase-12 modulates NOD signalling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 2008, 3:146-157.
98. Yeretssian G., Doiron K., Shao W., Leavitt B.R., Hayden M.R., Nicholson D.W., Saleh M. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9016-9020.
99. Miu J., Saleh M., Stevenson M.M. Caspase-12 deficiency enhances cytokine responses but does not protect against lethal Plasmodium yoelii 17XL infection. Parasite Immunol. 2010, 32:773-778.
100. Wang P., Arjona A., Zhang Y., Sultana H., Dai J., Yang L., LeBlanc P.M., Doiron K., Saleh M., Fikrig E. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat. Immunol. 2010, 11:912-919.
101. Oberst A., Green D.R. It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 2011, 12:757-763.
102. Kovalenko A., Kim J.C., Kang T.B., Rajput A., Bogdanov K., Dittrich-Breiholz O., Kracht M., Brenner O., Wallach D. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 2009, 206:2161-2177.
103. Takahashi K., Kawai T., Kumar H., Sato S., Yonehara S., Akira S. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J. Immunol. 2006, 176:4520-4524.
104. Rajput A., Kovalenko A., Bogdanov K., Yang S.H., Kang T.B., Kim J.C., Du J., Wallach D. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 2011, 34:340-351.
105. Lemmers B., Salmena L., Bidere N., Su H., Matysiak-Zablocki E., Murakami K., Ohashi P.S., Jurisicova A., Lenardo M., Hakem R., Hakem A. Essential role for caspase-8 in Toll-like receptors and NFkappaB signalling. J. Biol. Chem. 2007, 282:7416-7423.
106. Maelfait J., Vercammen E., Janssens S., Schotte P., Haegman M., Magez S., Beyaert R. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J. Exp. Med. 2008, 205:1967-1973.
107. Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat. Immunol. 2012, 13:246-254.
108. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276.
109. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., Caspary T., Mocarski E.S. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
110. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
111. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., Xavier R., Green D.R., Ting A.T. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 2011, 13:1437-1442.
112. Gunther C., Martini E., Wittkopf N., Amann K., Weigmann B., Neumann H., Waldner M.J., Hedrick S.M., Tenzer S., Neurath M.F., Becker C. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
113. Bruey J.M., Bruey-Sedano N., Luciano F., Zhai D., Balpai R., Xu C., Kress C.L., Bailly-Maitre B., Li X., Osterman A., Matsuzawa S., Terskikh A.V., Faustin B., Reed J.C. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129:45-56.
114. Faustin B., Chen Y., Zhai D., Le Negrate G., Lartigue L., Satterthwait A., Reed J.C. Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3935-3940.
115. Yeretssian G., Correa R.G., Doiron K., Fitzgerald P., Dillon C.P., Green D.R., Reed J.C., Saleh M. Non-apoptotic role of BID in inflammation and innate immunity. Nature 2011, 474:96-99.
116. Luo W., Li J., Zhang D., Cai T., Song L., Yin X.M., Desai D., Amin S., Chen J., Huang C. Bid mediates anti-apoptotic COX-2 induction through the IKKbeta/NFkappaB pathway due to 5-MCDE exposure. Curr. Cancer Drug Targets 2010, 10:96-106.
117. Askari N., Correa R.G., Zhai D., Reed J.C. Expression, purification, and characterization of recombinant NOD1 (NLRC1): a NLR family member. J. Biotechnol. 2012, 157:75-81.
118. Crook N.E., Clem R.J., Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 1993, 67:2168-2174.
119. Yang Y., Fang S., Jensen J.P., Weissman A.M., Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000, 288:874-877.
120. Blankenship J.W., Varfolomeev E., Goncharov T., Fedorova A.V., Kirkpatrick D.S., Izrael-Tomasevic A., Phu L., Arnott D., Aghajan M., Zobel K., Bazan J.F., Fairbrother W.J., Deshayes K., Vucic D. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem. J. 2009, 417:149-160.
121. Gyrd-Hansen M., Darding M., Miasari M., Santoro M.M., Zender L., Xue W., Tenev T., da Fonseca P.C., Zvelebil M., Bujnicki J.M., Lowe S., Silke J., Meier P. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat. Cell Biol. 2008, 10:1309-1317.
122. Lopez J., John S.W., Tenev T., Rautureau G.J., Hinds M.G., Francalanci F., Wilson R., Broemer M., Santoro M.M., Day C.L., Meier P. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol. Cell 2011, 42:569-583.
123. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., Shi Y. Structural basis of caspase-7 inhibition by XIAP. Cell 2001, 104:769-780.
124. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., Wu H. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 2001, 104:781-790.
125. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., Liddington R.C., Salvesen G.S. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001, 104:791-800.
126. Silke J., Ekert P.G., Day C.L., Hawkins C.J., Baca M., Chew J., Pakusch M., Verhagen A.M., Vaux D.L. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. EMBO J. 2001, 20:3114-3123.
127. Sun C., Cai M., Gunasekera A.H., Meadows R.P., Wang H., Chen J., Zhang H., Wu W., Xu N., Ng S.C., Fesik S.W. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 1999, 401:818-822.
128. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., Alnemri E.S., Fairman R., Shi Y. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 2003, 11:519-527.
129. Srinivasula S.M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J., Lee R.A., Robbins P.D., Fernandes-Alnemri T., Shi Y., Alnemri E.S. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001, 410:112-116.
130. Schile A.J., Garcia-Fernandez M., Steller H. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 2008, 22:2256-2266.
131. Huang H., Joazeiro C.A., Bonfoco E., Kamada S., Leverson J.D., Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 2000, 275:26661-26664.
132. Choi Y.E., Butterworth M., Malladi S., Duckett C.S., Cohen G.M., Bratton S.B. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 2009, 284:12772-12782.
133. Suzuki Y., Nakabayashi Y., Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8662-8667.
134. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 2010, 10:561-574.
135. Huh J.R., Foe I., Muro I., Chen C.H., Seol J.H., Yoo S.J., Guo M., Park J.M., Hay B.A. The Drosophila inhibitor of apoptosis (IAP) DIAP2 is dispensable for cell survival, required for the innate immune response to gram-negative bacterial infection, and can be negatively regulated by the reaper/hid/grim family of IAP-binding apoptosis inducers. J. Biol. Chem. 2007, 282:2056-2068.
136. Leulier F., Lhocine N., Lemaitre B., Meier P. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol. Cell. Biol. 2006, 26:7821-7831.
137. Paquette N., Broemer M., Aggarwal K., Chen L., Husson M., Erturk-Hasdemir D., Reichhart J.M., Meier P., Silverman N. Caspase-mediated cleavage, IAP binding, and ubiquitination: linking three mechanisms crucial for Drosophila NF-kappaB signalling. Mol. Cell 2010, 37:172-182.
138. Bauler L.D., Duckett C.S., O'Riordan M.X. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog. 2008, 4:e1000142.
139. Bertrand M.J., Doiron K., Labbe K., Korneluk R.G., Barker P.A., Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signalling by the pattern recognition receptors NOD1 and NOD2. Immunity 2009, 30:789-801.
140. Krieg A., Correa R.G., Garrison J.B., Le Negrate G., Welsh K., Huang Z., Knoefel W.T., Reed J.C. XIAP mediates NOD signalling via interaction with RIP2. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14524-14529.
141. Park J.H., Kim Y.G., McDonald C., Kanneganti T.D., Hasegawa M., Body-Malapel M., Inohara N., Nunez G. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 2007, 178:2380-2386.
142. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 2007, 282:36223-36229.
143. Tseng P.H., Matsuzawa A., Zhang W., Mino T., Vignali D.A., Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 2010, 11:70-75.
144. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439:208-211.
145. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.-C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., Mann M., Karin M. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439:204-207.
146. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., Cain K., MacFarlane M., Hacker G., Leverkus M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43:449-463.
147. Weber A., Kirejczyk Z., Besch R., Potthoff S., Leverkus M., Hacker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ. 2010, 17:942-951.
148. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., Zachariou A., Lopez J., MacFarlane M., Cain K., Meier P. The Ripoptosome, a signalling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 2011, 43:432-448.
149. Bertrand M.J., Milutinovic S., Dickson K.M., Ho W.C., Boudreault A., Durkin J., Gillard J.W., Jaquith J.B., Morris S.J., Barker P.A. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 2008, 30:689-700.
150. Labbe K., McIntire C.R., Doiron K., Leblanc P.M., Saleh M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011, 35:897-907.
151. Vince J.E., Wong W.W., Gentle I., Lawlor K.E., Allam R., O'Reilly L., Mason K., Gross O., Ma S., Guarda G., Anderton H., Castillo R., Hacker G., Silke J., Tschopp J. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
152. Mao A.P., Li S., Zhong B., Li Y., Yan J., Li Q., Teng C., Shu H.B. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J. Biol. Chem. 2010, 285:9470-9476.